Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mary Lynne Hedley currently holds 2,252.69 shares of Abraxis BioScience, Inc. (ABII), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mary Lynne Hedley has been a net seller of ABII stock. They have purchased $0 and sold $1.1M worth of shares.
Mary Lynne Hedley's most recent insider trade was on Dec 15, 2025, when they sold 9.34 shares at $1062.19 per share.
Mary Lynne Hedley serves as Executive at Abraxis BioScience, Inc. (ABII). They have executed 102 insider transactions totaling $1.1M over their tenure at the company.
Mary Lynne Hedley holds the position of Executive at Abraxis BioScience, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Mary Lynne Hedley has shown a selling trading pattern, with $0 in total purchases and $1.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mary Lynne Hedley was on Nov 17, 2025, when they purchased $220.0K worth of LLY shares. This transaction involved 215.33 shares at $1021.70 per share.
Mary Lynne Hedley currently owns 2,252.69 shares of Abraxis BioScience, Inc. (ABII), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mary Lynne Hedley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mary Lynne Hedley has 102 Form 4 filings on record as an insider at Abraxis BioScience, Inc..
Set alerts for Mary Lynne Hedley and 40,000+ other insiders.